SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037925
Filing Date
2023-08-03
Accepted
2023-08-03 16:01:00
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omga-20230630.htm   iXBRL 10-Q 3202290
2 EX-10.1 omga-ex10_1.htm EX-10.1 154734
3 EX-31.1 omga-ex31_1.htm EX-31.1 20713
4 EX-31.2 omga-ex31_2.htm EX-31.2 20427
5 EX-32.1 omga-ex32_1.htm EX-32.1 11885
6 EX-32.2 omga-ex32_2.htm EX-32.2 11584
7 GRAPHIC img33839852_0.jpg GRAPHIC 14727
  Complete submission text file 0000950170-23-037925.txt   10978492

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT omga-20230630.xsd EX-101.SCH 73820
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT omga-20230630_pre.xml EX-101.PRE 406432
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT omga-20230630_cal.xml EX-101.CAL 50517
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT omga-20230630_lab.xml EX-101.LAB 553691
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT omga-20230630_def.xml EX-101.DEF 244452
78 EXTRACTED XBRL INSTANCE DOCUMENT omga-20230630_htm.xml XML 1894392
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40657 | Film No.: 231139714
SIC: 2836 Biological Products, (No Diagnostic Substances)